Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
t-TUCB is a soluble epoxide hydrolase (sEH) inhibitor (IC50s = 0.4, 3.1, and 11.9 nM for the human, mouse, and rat enzymes, respectively).1 It also inhibits fatty acid amide hydrolase (FAAH; IC50 = 260 nM for the human enzyme). t-TUCB (3 mg/kg) increases the mechanical paw withdrawal threshold in a mouse model of diabetic neuropathic pain induced by streptozotocin (Item No. 13104).1 It prevents EKG abnormalities induced by the β1- and β2-adrenergic receptor agonist isoproterenol (Item No. 15592), as well as reduces isoproterenol-induced increases in infarct size and heart weight, in a rat model of myocardial ischemia when administered at doses of 3, 10, and 30 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive. Pharmacol. Res. 97, 7-15 (2015).
2. Soluble epoxide hydrolase inhibitor, t-